immunity News and Research

RSS

ACS Infectious Diseases journal highlights chemistry and collaborative research area

The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.

11 Jul 2014

Viewpoints: Misreading Hobby Lobby; calmer climate for ACA; danger of tuberculosis, measles

Liberals should spend less time lauding the dissents in last week's Hobby Lobby decision by the U.S. Supreme Court and more time reading them.

9 Jul 2014

UC Riverside discovery could lead to future development of needle-free vaccines

Ripping a page from the Star Trek script, specialized cells of the barrier that lines the inside of the intestines and airways of humans have invoked a biological version of Captain Kirk's famous command "shields up" as a first defense against invading microbes.

8 Jul 2014

Researcher describes possible implications of increased gravity effect on immunity

Before you swat away the next fruit fly, consider instead just how similar its biological complexities are to our own.

4 Jul 2014

Research: New protein complex fights against bacterial infection that causes gastric cancer

New study by Cancer Science Institute of Singapore at NUS show that the protein is produced as an immune response and requires the tumour suppressor RUNX3.

4 Jul 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

SEC sues after House Resists insider trading probe

The Securities and Exchange Commission has sued a House committee and its staff director in federal court to enforce subpoenas for documents and testimony about possible tipping of confidential government information about a planned change in Medicare reimbursement rates that reached investors and sent health insurance stocks soaring.

25 Jun 2014

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.

24 Jun 2014

First Edition: June 24, 2014

Today's headlines include news about the latest report detailing problems at the VA.

24 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

Western Oncolytics closes $275,000 in seed funding

Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill cancer cells.

18 Jun 2014

GENETICS and G3: Genes|Genomes|Genetics publish special collection on genetics of immunity

Immunity is what stops you dying from a common cold or a tiny pinprick. Differences in resistance or tolerance to disease influence who catches the bug that's going around the office, or which species succumb to the deadly fungus devastating frogs around the world.

18 Jun 2014

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Dengue is a mosquito-transmitted viral infection. The disease is widespread in tropical and sub-tropical climates and most commonly found in urban areas. Around half of the world's population are now estimated to live in dengue endemic regions.

16 Jun 2014

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.

10 Jun 2014

Batu Biologics reports FDA development plans for cancer immunotherapeutic vaccine ValloVax

Batu Biologics announced today FDA development plans for its patent-pending lead product, ValloVax, a cancer immunotherapeutic "vaccine" that specifically targets the tumor blood vessels (endothelium).

9 Jun 2014

Device used in physics and chemistry reveals dynamics of pervasive pathogen

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.

6 Jun 2014

American College of Gastroenterology develops new podcast for World Digestive Health Day

For World Digestive Health Day, the American College of Gastroenterology, along with World Gastroenterology Organisation (WGO), observes the 2014 focus on the human gut microbiome and its impact on health and disease. Scientific understanding of the gut microbiome - the diverse and complex microbial community that resides in the intestine - has rapidly evolved in recent years.

31 May 2014

immunity News and Research

ACS Infectious Diseases journal highlights chemistry and collaborative research area

Viewpoints: Misreading Hobby Lobby; calmer climate for ACA; danger of tuberculosis, measles

UC Riverside discovery could lead to future development of needle-free vaccines

Researcher describes possible implications of increased gravity effect on immunity

Research: New protein complex fights against bacterial infection that causes gastric cancer

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

SEC sues after House Resists insider trading probe

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

First Edition: June 24, 2014

Study reveals that inflammasomes remain active even after cell death

Western Oncolytics closes $275,000 in seed funding

GENETICS and G3: Genes|Genomes|Genetics publish special collection on genetics of immunity

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Celsion signs definitive asset purchase agreement to acquire EGEN

Batu Biologics reports FDA development plans for cancer immunotherapeutic vaccine ValloVax

Device used in physics and chemistry reveals dynamics of pervasive pathogen

American College of Gastroenterology develops new podcast for World Digestive Health Day

New approach could lead to more effective HIV vaccine

Employers to implement mandatory influenza vaccination policies for health care workers

Growing resistance to antibiotics demands a coordinated global response, say experts

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News